{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T17:17:06Z","timestamp":1747156626514,"version":"3.40.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.bulcan.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,9,10]],"date-time":"2024-09-10T23:29:12Z","timestamp":1726010952000},"page":"989-991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["R\u00e9action auto-inflammatoire type maladie de Still induite par le nivolumab"],"prefix":"10.1016","volume":"111","author":[{"given":"St\u00e9phanie","family":"Hermabessi\u00e8re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Palassin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Quantin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre T.J.","family":"Maria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0193-1803","authenticated-orcid":false,"given":"Cyrille","family":"Coustal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bulcan.2024.05.009_bib0050","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.semarthrit.2021.06.004","article-title":"Adult-onset Still's disease in focus: clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies","volume":"51","author":"Efthimiou","year":"2021","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.bulcan.2024.05.009_bib0055","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3390\/jcm12051985","article-title":"Hemophagocytic lymphohistiocytosis associated with immunological checkpoint inhibitors: a pharmacovigilance study","volume":"12","author":"Diaz","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.bulcan.2024.05.009_bib0060","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.07.018","article-title":"A comprehensive review on adult onset Still's disease","volume":"93","author":"Giacomelli","year":"2018","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.bulcan.2024.05.009_bib0065","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.bulcan.2024.05.009_bib0070","doi-asserted-by":"crossref","first-page":"102980","DOI":"10.1016\/j.jaut.2022.102980","article-title":"Comprehensive description of adult-onset Still's disease after COVID-19\u00a0vaccination","volume":"134","author":"Palassin","year":"2023","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.bulcan.2024.05.009_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0248-8663(88)80047-X","article-title":"Pseudo-maladie de Still et n\u00e9oplasie. Deux observations [Pseudo-Still disease and neoplasm. 2\u00a0cases]","volume":"9","author":"Cabane","year":"1988","journal-title":"Rev Med Interne"},{"issue":"5","key":"10.1016\/j.bulcan.2024.05.009_bib0080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","article-title":"Adult-onset Still disease","volume":"22","author":"Fautrel","year":"2008","journal-title":"Best Pract Res Clin Rheumatol."},{"issue":"5","key":"10.1016\/j.bulcan.2024.05.009_bib0085","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.23415","article-title":"Low glycosylated ferritin, a good marker for the diagnosis of hemophagocytic syndrome","volume":"58","author":"Fardet","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.bulcan.2024.05.009_bib0045","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.semarthrit.2017.07.005","article-title":"Validation of the Fautrel classification criteria for adult-onset Still's disease","volume":"47","author":"Lebrun","year":"2018","journal-title":"Semin Arthritis Rheum"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124002558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455124002558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T21:05:20Z","timestamp":1727125520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455124002558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0007455124002558"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.05.009","relation":{},"ISSN":["0007-4551"],"issn-type":[{"type":"print","value":"0007-4551"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"R\u00e9action auto-inflammatoire type maladie de Still induite par le nivolumab","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}